EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of the registrant certify, to the best of their knowledge, that the registrant’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Form 10-Q, fairly presents, in all material respects, the financial condition and results of operations of the registrant.
Bionexus Gene Lab Corporation |
|
|
|
Dated: May 12, 2022 |
|
|
|
/s/ Chan Chong Wong |
|
Chan Chong Wong Chief Executive Officer and Director (Principal Executive Officer) |
|
|
|
/s/ Wei Li Leong |
|
Wei Li Leong Chief Financial Officer (Principal Financial and Accounting Officer) |
|